Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
1978 • 560 citations
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
1979 • 471 citations
Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with Acyclovir
1982 • 345 citations
Acute and Recurrent Infection with Herpes Simplex Virus in the Mouse: a Model for Studying Latency and Recurrent Disease
1975 • 337 citations
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice
1978 • 337 citations
Induction of Both Thymidine and Deoxycytidine Kinase Activity by Herpes Viruses
1974 • 287 citations
Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.
1980 • 285 citations
Mutant strains of herpes simplex deficient in thymidine kinase-inducing activity
1964 • 255 citations
Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo
1980 • 245 citations
ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY
1982 • 239 citations
Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.
1980 • 229 citations
Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance
1981 • 208 citations
Trigeminal Ganglion Infection by Thymidine Kinase-Negative Mutants of Herpes Simplex Virus
1979 • 175 citations
BLOOD SUBSTITUTES
1974 • 167 citations
A virus-specific thymidine kinase in BHK21 cells infected with herpes simplex virus
1967 • 164 citations
Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion
1979 • 159 citations
Isolation and Characterization of Acyclovir-resistant Mutants of Herpes Simplex Virus
1980 • 152 citations
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
1980 • 130 citations
Cell-mediated Immunity in Herpes Simplex Virus-infected Mice: Induction, Characterization and Antiviral Effects of Delayed Type Hypersensitivity
1980 • 117 citations
Nucleoside analogues : chemistry, biology, and medical applications
1979 • 90 citations
Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells.
1981 • 84 citations
The Sensitivity of Acyclovir-Resistant Mutants of Herpes Simplex Virus to Other Antiviral Drugs
1981 • 77 citations
Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy
1982 • 76 citations
Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity
1981 • 70 citations
Effects of Oral Treatment with Acyclovir and Bromovinyldeoxyuridine on the Establishment and Maintenance of Latent Herpes Simplex Virus Infection in Mice
1981 • 56 citations
Acyclovir — A review of the preclinical and early clinical data of a new antiherpes drug
1981 • 48 citations
Antiviral chemotherapy : design of inhibitors of viral functions
1981 • 33 citations
Efficacy of E-5-(2-Bromovinyl)-2′-Deoxyuridine in the Topical Treatment of Herpetic Keratitis in Rabbits and Man
1981 • 12 citations
Strategies of drug resistance in herpes simplex
1980 • 10 citations
Cited By (0)
No citing papers found in database